| 27th Aug 2019 7:00 am |
RNS |
Total Voting Rights and Directors' Shareholdings |
| 8th Aug 2019 10:45 am |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Nearing the end-goal |
| 7th Aug 2019 7:00 am |
RNS |
Issue of equity and new debt facility |
| 6th Aug 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
| 6th Aug 2019 11:00 am |
RNS |
Price Monitoring Extension |
| 25th Jul 2019 5:12 pm |
RNS |
Result of AGM |
| 25th Jul 2019 7:00 am |
RNS |
AGM Statement & Technological update |
| 22nd Jul 2019 7:00 am |
RNS |
Harley Street update |
| 28th Jun 2019 7:00 am |
RNS |
Final Results |
| 3rd Jun 2019 7:00 am |
RNS |
Technological update |
| 31st May 2019 5:30 pm |
RNS |
Total Voting Rights |
| 17th May 2019 5:29 pm |
RNS |
Holding(s) in Company |
| 16th May 2019 2:23 pm |
EQS |
Advanced Oncotherapy (AVO-GB): Strong fundamentals underpin future growth |
| 13th May 2019 12:20 pm |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Commercialising a breakthrough technology |
| 10th May 2019 7:00 am |
RNS |
Debt facility secured |
| 16th Apr 2019 10:26 am |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Preparing for commercialisation |
| 16th Apr 2019 9:12 am |
EQS |
Advanced Oncotherapy (AVO-GB): Key talent acquisition reaffirms the promise of LIGHT |
| 16th Apr 2019 7:00 am |
RNS |
Senior Management Appointment |
| 7th Mar 2019 9:00 am |
RNS |
Price Monitoring Extension |
| 22nd Feb 2019 7:00 am |
RNS |
Grant of options |
| 1st Feb 2019 7:00 am |
RNS |
Appointment of Nominated Adviser and Joint Broker |
| 30th Jan 2019 11:45 am |
RNS |
Schedule 2(g) Disclosure |
| 29th Jan 2019 9:38 am |
RNS |
Total Voting Rights and Significant Shareholdings |
| 24th Jan 2019 12:14 pm |
RNS |
Schedule 2(g) Disclosure |
| 22nd Jan 2019 3:29 pm |
RNS |
Result of General Meeting |
| 21st Jan 2019 11:15 am |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Important regulatory milestone: ISO approval |
| 21st Jan 2019 7:00 am |
RNS |
ISO 13485:2016 certification for medical devices |
| 21st Dec 2018 10:15 am |
RNS |
Launch of 2018 SAYE Scheme |
| 21st Dec 2018 7:00 am |
RNS |
Proposed Direct Subscription to raise £10.0m |
| 16th Oct 2018 4:31 pm |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Four components integrated |
| 16th Oct 2018 3:58 pm |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement |
| 10th Oct 2018 7:30 am |
RNS |
GPSL Research - Flash Note on AVO |
| 10th Oct 2018 7:00 am |
RNS |
Technological update |
| 4th Oct 2018 11:07 am |
RNS |
GPSL Research - Flash Note on AVO |
| 28th Sep 2018 7:00 am |
RNS |
Half-year Report |
| 27th Sep 2018 7:00 am |
RNS |
Technological update |
| 10th Sep 2018 11:32 am |
RNS |
Holding(s) in Company |
| 7th Sep 2018 11:52 am |
RNS |
Holding(s) in Company |
| 3rd Sep 2018 5:15 pm |
EQS |
Hardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement |
| 3rd Sep 2018 11:38 am |
RNS |
Completion of the £6.41m Placing |
